Blood test may replace biopsies for rare lymphoma monitoring
NCT ID NCT06089941
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether analyzing tumor DNA from blood samples (called ctDNA) can be a reliable way to monitor peripheral T-cell lymphoma, a rare blood cancer. Researchers will take blood from 45 patients at diagnosis, during treatment, and at relapse to see if the method works. The goal is to find out if this non-invasive approach can track the cancer as well as standard tissue biopsies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could lead to a simple blood test to track lymphoma and guide treatment decisions without repeated tissue biopsies.
What could go wrong
This is a small, early feasibility study (45 people) that only checks if the method works. It does not test a treatment, so even if successful, it may not directly improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL T CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Henri Becquerel
Rouen, France